Utvendig Renhold ble startet i 2010 med formål om å utføre vinduspuss for private og bedrifter. Etterhvert ble omfanget av tjenester mye større enn bare klassisk vinduspuss og omfatter nå alt utvendig renhold av bygninger for både private og næringsbygg .Selskapet har vært i konstant utvikling når det gjelder å ta i bruk nye metoder og ny teknologi. Dette har kommet kunder til gode, og gitt bedre kundeopplevelser. Vi holder i dag til i Kristiansand hvor vi har en etablert virksomhet. Vårt slogan er "Ingen strekker seg lenger" og betyr at vi leverer tjenester i verdensklasse. Dette klarer vi ved å levere riktig løsning, benytte riktig utstyr og ha en innovativ kompetanse på området til enhver tid.Vi ønsker å etablere Utvendig Renhold sitt konsept i de største byene i Norge. Dette skal vi gjøre gjennom etablering av franchiser i de ulike byene.

AVISOMO is developing indoor growing modules for farmers. These modules have an integrated regulation system that automatically cares for the environment inside and outside the module. The environment being nutrients in the hydroponic nutrient solution, pH levels, temperature, CO2 levels, light intensity and so on. This regulator is what makes this technology available to everyone. The regulation technology combined with top-shelf advanced LED makes our modules the best way to increase a farmer's yield more cost- and labour-effective.

Vi produserer innhold og reklamemateriell med mening. Park Pixel er et ungt selskap som jobber i et ellers overfylt fagfelt. Vi forsøker å opprettholde og fremvise en høy standard for innholdsproduksjon og reklame. Selskapet holder til i Sarpsborg som er en fortsatt oppegående by i et nedlagt fylke som engang het Østfold. Hvordan skiller vi oss ut fra konkurrentene? Vi legger inn det lille ekstra med tid og fokus på de må detaljene. Vi opprettholder personlig kundekontakt og det er viktig for oss at våre kunder skal være fornøyde og stolt av produktetene vi leverer.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

LifeTools AS develops digital tools for people with complex needs within the fields of communication, cognition, and challenged behavior. We put the user first and develop dynamic systems with high flexibility based on the unique user's needs. The network around the user will have digital tools to observe, build and publish expressions, routines, and activities into our systems, and use this information back into the interaction with the user. This gives a better foundation in communication and helps increase the quality of life for the user. Our philosophy is to use "everyday technology" such as tablets/phones and cloud-based solutions and develop highly intuitive and dynamic tools for the network. Users (people with special and complex needs) therefore do not need to acquire skills or knowledge in order to use our systems. This makes it easier for those who have great cognitive challenges to make use of our technological solutions.

The founder of Dynamisk Helse, Ann-Kristin Johansen, worked for several years as a nurse in hospitals and elderly care organizations. She experienced first-hand the lack of proper training which sometimes led to negative incidences for the patients as well as the staff. Sometimes the result had devastating outcomes, with a person's life at risk. Ann-Kristin felt sad and angry and felt the need to personally take action. This resulted in the foundation of Dynamisk Helse AS in 2011. We believe in small drops of theoretical and practical case-specific training, tailored naturally into our daily work. As there was no software platform available we felt was appropriate, we made it ourselves. Starting with making the “Drops first aid” app, which received fantastic feedback around the globe. (still available in Appstore) After this first test of response, we continued developing our own philosophy into a software platform that exceeds normal standards today. With limitless scalability and access on all digital surfaces. The number of elderly and inhabitants with chronic diseases, is going to double within ten years, resulting in dramatic demand for qualified healthcare workers. The leaders in healthcare struggle with high turnover and a shortage of both time and recourses to train the temps. Drops smartphone solution gives access to short and precise information about what to do when they need it, by scanning a QR code. Our Drops Skill aid system enables healthcare leaders to support staff in day-to-day tasks. We save costs for our customers, and provide a better service for patients, while we support care workers in building their skills and confidence.

BRIK as is a company specialising in new web technology, pedagogy and professional dissemination of knowledge. The team has extensive experience in the dissemination of knowledge with new web technologies and video. Our investors and partners are Innovation Norway, the Norwegian Research Council and several customer partners. The budget for the initial development phase (2013 - ) has been 12 MNOK. Now we are looking for partners for the next stage, where we will commercialize and increase sales.

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.

Game-changing technology for structural integrity monitoring. The Ferrx FEMM (Ferrx ElectroMagnetic Method) has been developed and tested for 2 decades, first by SINTEF and since 2005 by Ferrx. The method has provided unique features for the condition monitoring of steel structures. Material deterioration can be directly measured and early warning of risk for fatigue can be established long before any crack is detectable. Furthermore, the same sensors can also measure changes in metal loss, and thus provide for non-intrusive monitoring of internal corrosion and erosion in pipes. During the last years, instrumentation technology has been industrialized and the first commercial systems have been delivered and installed. Different types of instrumentation systems are available both for onshore and offshore/subsea applications. The industrialization, marinization, and production of the instrumentation systems are being done in cooperation with the most specialized suppliers. Ferrx is an independent company located in Trondheim, Norway with the business idea to provide the FEMM technology for different onshore and offshore markets to monitor the actual condition of steel structures and thus prevent loss of assets and pollution of the environment. The FEMM is protected by 2 patents and all rights are vested in Ferrx. The system for riser inspection has been qualified by DNV-GL in accordance with DNV-RP-A203 Technology Qualification.

ICT is a Norwegian technology development company that holds patents designed to bring new opportunities to the cryogenic liquids storage and transportation sectors via unique containers. The design targets the market for both large- and small-scale cryogenic applications. ICT’s solution is modular and suited for onshore as well as maritime use. The development of hydrogen infrastructure is slow and holding back widespread adoption. Transportation of large volumes is one of the major challenges that IC Technologies is determined to solve. Another challenge is the storage of liquid hydrogen. Current storage solutions resemble enlarged thermos flasks, and the hydrogen inside gradually evaporates over time. Our vision is a decarbonized world with green hydrogen as a major energy carrier.

Verden trenger helt nye mobilitetsløsninger for å nå de ambisiøse bærekraftsmålene – og Joule er med på å skape den fremtiden. Joule er en norsk startup som baner vei for neste generasjon mobilitet. Vi tilbyr abonnement for elsykkel – et populært og miljøvennlig produkt med gode vekstutsikter. Våre verdier er:BærekraftLikeverdIntegritetNysgjerrighetJoule har en industriell eier i ryggen og såkornsfinansiering er på plass.

The Norwegian fashion brand BRGN was founded in 2015 by Ros-Mari Tobiassen Gaundal and Karine Trellevik Lunde. Their mission is to offer great alternatives to the traditional all-weather jacket, through high-quality garments and shoes that can be worn on any occasion and in any kind of weather. Their technical and waterproof products, designed for a functional and urban lifestyle, are now sold by over a hundred retailers in Norway, Germany, France, and the UK in addition to their two concept stores in Oslo and Bergen. BRGN set a new turnover record in 2021, at 25.8 MNOK. Up from 16. MNOK in 2020.

Morgenlevering.no gjør dagen lysere!✨ Vi gjør det enkelt å få en god start på dagen til deg selv eller noen du er glad i. Med nybakt brød, bakevarer, juice, aviser og mye mer levert hjem til deg før du våkner. Bestill dagen før og kos deg med en god frokost både til hverdags og i helgen. Du bestiller akkurat så lite eller så mye du vil. Bestill enkelt på morgenelvering.no eller via appen vår som du finner i App-store og på Android😄